Page last updated: 2024-10-27

flurbiprofen and Biliary or Urinary Stones

flurbiprofen has been researched along with Biliary or Urinary Stones in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, YG1
Hu, LH1
Chen, H1
Li, B1
Fan, XH1
Li, JB1
Wang, JF1
Deng, XM1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT01998217]Phase 460 participants (Actual)Interventional2012-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for flurbiprofen and Biliary or Urinary Stones

ArticleYear
Target-controlled infusion of remifentanil with or without flurbiprofen axetil in sedation for extracorporeal shock wave lithotripsy of pancreatic stones: a prospective, open-label, randomized controlled trial.
    BMC anesthesiology, 2015, Nov-07, Volume: 15

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arterial Pressure; Calculi; Drug Therapy, Combinatio

2015